Artículos por temáticas

Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson's disease and inflammatory pathways.

Elmazoglu Z, Yar Saglam AS, Sonmez C, Karasu C.

Drug Chem Toxicol. 2020 Jan;43(1):96-103. doi: 10.1080/01480545.2018.1504961. Epub 2018 Sep 12.

Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery.

Wodushek TR, Domen CH.

Appl Neuropsychol Adult. 2020 Jan-Feb;27(1):9-21. doi: 10.1080/23279095.2018.1473251. Epub 2018 Sep 5.

Application of telehealth intervention in Parkinson's disease: A systematic review and meta-analysis.

Chen YY, Guan BS, Li ZK, Yang QH, Xu TJ, Li HB, Wu QY.

J Telemed Telecare. 2020 Jan-Feb;26(1-2):3-13. doi: 10.1177/1357633X18792805. Epub 2018 Aug 28. Erratum in: J Telemed Telecare. 2020 Jan-Feb;26(1-2):119.

Exploring the uptake and implementation of tele-monitored home-exercise programmes in adults with Parkinson's disease: A mixed-methods pilot study.

Lai B, Bond K, Kim Y, Barstow B, Jovanov E, Bickel CS.

J Telemed Telecare. 2020 Jan-Feb;26(1-2):53-63. doi: 10.1177/1357633X18794315. Epub 2018 Aug 22.

Effectiveness of ReSET; a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease.

Vlagsma TT, Duits AA, Dijkstra HT, van Laar T, Spikman JM.

Neuropsychol Rehabil. 2020 Jan;30(1):67-84. doi: 10.1080/09602011.2018.1452761. Epub 2018 Mar 22.

Low-Dose Naltrexone reduces symptoms in Stiff-Person Syndrome

Zappaterra M, Shouse E, Levine RL.

Med Hypotheses. 2020 Apr;137:109546. doi: 10.1016/j.mehy.2019.109546. Epub 2020 Jan 2.

Retinal pathology occurs in stiff-person syndrome

Lambe J, Rothman A, Prince J, Saidha S, Calabresi PA, Newsome SD.

Neurology. 2020 May 19;94(20):e2126-e2131. doi: 10.1212/WNL.0000000000008943. Epub 2020 Jan 10.

Rituximab improves not only back stiffness but also "stiff eyes" in stiff person syndrome: Implications for immune-mediated treatment.

Kodama S, Tokushige SI, Sugiyama Y, Sato K, Otsuka J, Shirota Y, Hamada M, Iwata A, Toda T, Tsuji S, Terao Y.

J Neurol Sci. 2020 Jan 15;408:116506. doi: 10.1016/j.jns.2019.116506. Epub 2019 Nov 2.

Prevalence and Risk Factors of Restless Legs Syndrome in Hemodialysis Patients

Zhang LY, Ma XY, Lin J, Liu WH, Guo W, Yin L, Wang SX, Li X, Li J, Jin LL, Tian ZL, Du YT, Tuo HZ.

Nat Sci Sleep. 2020 Jan 14;12:19-27. doi: 10.2147/NSS.S236393. eCollection 2020.

Acupuncture for restless legs syndrome: A systematic review and meta-analysis protocol

Huang K, Liang S, Han D, Guo R, Chen L, Grellet A.

Medicine (Baltimore). 2020 Jan;99(3):e18902. doi: 10.1097/MD.0000000000018902.

[Restless legs syndrome]

Vellieux G, d'Ortho MP.

Rev Med Interne. 2020 Apr;41(4):258-264. doi: 10.1016/j.revmed.2020.01.001. Epub 2020 Jan 29.

Brain regions associated with periodic leg movements during sleep in restless legs syndrome

Kim TJ, Cha KS, Lee S, Yang TW, Kim KT, Park BS, Jun JS, Lim JA, Byun JI, Sunwoo JS, Shin JW, Kim KH, Lee SK, Jung KY.

Sci Rep. 2020 Jan 31;10(1):1615. doi: 10.1038/s41598-020-58365-0.

Restless legs syndrome and periodic limb movements of sleep

O'Regan D, Anderson KN.

Br J Hosp Med (Lond). 2020 Jan 2;81(1):1-8. doi: 10.12968/hmed.2019.0319. Epub 2020 Jan 28.

Prevalence of restless legs syndrome among pregnant women: A case-control study

Almeneessie AS, Alyousefi N, Alzahrani M, Alsafi A, Alotaibi R, Olaish AH, Sabr Y, Bahammam AS.

Ann Thorac Med. 2020 Jan-Mar;15(1):9-14. doi: 10.4103/atm.ATM_206_19. Epub 2020 Jan 2.

Restless legs syndrome is associated with mast cell activation syndrome

Weinstock LB, Walters AS, Brook JB, Kaleem Z, Afrin LB, Molderings GJ.

J Clin Sleep Med. 2020 Mar 15;16(3):401-408. doi: 10.5664/jcsm.8216. Epub 2020 Jan 14.